Unknown

Dataset Information

0

The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges.

ABSTRACT:

SUBMITTER: Piciocchi A 

PROVIDER: S-EPMC7361722 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Similar Datasets

Unknown Challenges in operationalising clinical trials in India during the COVID-19 pandemic.
| S-EPMC8694703 | biostudies-literature
Unknown COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues.
| S-EPMC9128298 | biostudies-literature
Unknown Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic.
| S-EPMC7524598 | biostudies-literature
Unknown COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
| S-EPMC8220438 | biostudies-literature
Unknown Challenges and practices on waste management and disposal during COVID-19 pandemic.
| S-EPMC7869705 | biostudies-literature
Unknown Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
| S-EPMC8131060 | biostudies-literature
Unknown Large scale clinical trials: lessons from the COVID-19 pandemic.
| S-EPMC9198385 | biostudies-literature
Unknown Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.
| S-EPMC7705351 | biostudies-literature
Unknown The COVID-19 pandemic: a catalyst to improve clinical trials.
| S-EPMC7461742 | biostudies-literature
Unknown Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
| S-EPMC8164884 | biostudies-literature